The impact of intrauterine growth restriction on adiposity and small intestine morphology during postnatal development in pigs

Placenta ◽  
2019 ◽  
Vol 83 ◽  
pp. e75-e76
Author(s):  
Thaís Garcia Santos ◽  
Stefany Araújo ◽  
Saffir Fernandes ◽  
Fernando Felicioni ◽  
Thaís Domingues e Paula ◽  
...  
2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 121-121
Author(s):  
Amelia R Tanner ◽  
Asghar Ali ◽  
Quinton A Winger ◽  
Paul J Rozance ◽  
Russell V Anthony

Abstract Chorionic somatomammotropin (CSH) is one of the most abundant hormones produced by the sheep placenta, yet the exact function of CSH has been elusive. Previously we reported the use of in vivo RNA interference (RNAi) to assess the impact of CSH deficiency on placental and fetal growth in sheep. Near-term (135 dGA), there are two distinct CSH RNAi phenotypes: 1) pregnancies with intrauterine growth restriction (IUGR), and 2) pregnancies with normal fetal and placental weights. This study describes physiological changes in the latter phenotype. To generate the CSH RNAi pregnancies, the trophectoderm of hatched blastocysts (9 dGA) were infected with lentiviral-constructs expressing either a scrambled control (NTS) or CSH-specific shRNA (CSH RNAi), prior to transfer into synchronized recipient ewes. At 120 dGA, 6 NTS and 6 CSH RNAi pregnancies were fitted with maternal and fetal catheters. Uterine and umbilical blood flows were measured utilizing the 3H2O transplacental diffusion technique at 132 dGA, and nutrient uptakes were calculated by the Fick principle. Resulting data were analyzed by Student’s t-test and significance was set at P ≤ 0.05. CSH RNAi tended (P ≤ 0.10) to reduce placentome weight with no effect on fetal weight. Absolute (ml/min) and relative (ml/min/kg fetus) uterine blood flows were reduced (P ≤ 0.05) in CSH RNAi pregnancies, but umbilical flows were not impacted. The uterine artery-to-vein glucose gradient (mmol/l) was significantly (P ≤ 0.05) increased, whereas the gradients for taurine and glycine were reduced (P ≤ 0.05). Uteroplacental glucose uptake (mmol/min/kg placenta) was increased 27% (P ≤ 0.05), whereas umbilical glucose uptake (mmol/min/kg fetus) was reduced 13%. This cohort demonstrates that even in the absence of IUGR, CSH deficiency has significant physiological ramifications, and the investigation of CSH RNAi pregnancies exhibiting both IUGR and non-IUGR phenotypes may help determine the direct effects of CSH and its potential impact on fetal programming. Supported by NIH R01 HD093701.


Nutrients ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3399
Author(s):  
Yasaman Shahkhalili ◽  
Florence Blancher-Budin ◽  
Cathriona Monnard ◽  
Julie Moulin ◽  
José Sanchez-Garcia ◽  
...  

The impact of early life protein source (whey vs. casein) on short- and long-term glucose homeostasis and adiposity is unknown and was investigated in this study. At the end of the suckling period, non-IUGR (intrauterine growth restriction) and IUGR pups were separated from dams and were randomized into four groups. From age 21–49 days, non-IUGR and IUGR pups were fed ad-libitum chow or a semi-synthetic diet (20% from protein; casein or whey) and from age 50–199 days, all groups were fed ad-libitum chow. Food intake, body composition, glucose, and insulin homeostasis were assessed. Among the chow groups, IUGR had slower growth and higher fasting glucose at age 42 days, as well as higher fasting and AUC glucose at age 192 days relative to non-IUGR. The whey IUGR group had a slower growth rate and higher fasting glycemia in early life (age 21–49 days) and higher HOMA-IR later in life (age 120–122 and 190–192 days) relative to casein IUGR. This study shows the potential advantage of casein relative to whey during weaning on short term energy intake, growth, and glucose homeostasis in an IUGR model and reveals, for the first time, its long term impact on insulin sensitivity, which may have implications for later metabolic health, particularly in small-for-gestational-age populations at risk of type 2 diabetes.


2001 ◽  
Vol 34 (12) ◽  
pp. 1153-1159
Author(s):  
L. Gortner ◽  
M. van Husen ◽  
E. Landmann

Reproduction ◽  
2017 ◽  
Vol 153 (5) ◽  
pp. R163-R171 ◽  
Author(s):  
Nathanael Yates ◽  
Rachael C Crew ◽  
Caitlin S Wyrwoll

Maternal vitamin D deficiency has been implicated in a range of pregnancy complications including preeclampsia, preterm birth and intrauterine growth restriction. Some of these adverse outcomes arise from alterations in placental function. Indeed, vitamin D appears critical for implantation, inflammation, immune function and angiogenesis in the placenta. Despite these associations, absence of the placental vitamin D receptor in mice provokes little effect. Thus, interactions between maternal and fetal compartments are likely crucial for instigating adverse placental changes. Indeed, maternal vitamin D deficiency elicits changes in glucocorticoid-related parameters in pregnancy, which increase placental and fetal glucocorticoid exposure. Asin uteroglucocorticoid excess has a well-established role in eliciting placental dysfunction and fetal growth restriction, this review proposes that glucocorticoids are an important consideration when understanding the impact of vitamin D deficiency on placental function and fetal development.


Placenta ◽  
2020 ◽  
Vol 99 ◽  
pp. 50-62
Author(s):  
Grace M. McBride ◽  
Michael D. Wiese ◽  
Jia Yin Soo ◽  
Jack R.T. Darby ◽  
Mary J. Berry ◽  
...  

2020 ◽  
Vol 236 (5) ◽  
pp. 840-853 ◽  
Author(s):  
Fernando Felicioni ◽  
Andreia D. Pereira ◽  
Andre L. Caldeira‐Brant ◽  
Thais G. Santos ◽  
Thais M. D. Paula ◽  
...  

2008 ◽  
Vol 138 (1) ◽  
pp. 60-66 ◽  
Author(s):  
Junjun Wang ◽  
Lixiang Chen ◽  
Defa Li ◽  
Yulong Yin ◽  
Xiaoqiu Wang ◽  
...  

Perinatologia ◽  
2017 ◽  
Vol 1 (1) ◽  
pp. 6
Author(s):  
Monica Mihaela Cîrstoiu ◽  
Natalia Turcan ◽  
Roxana-Elena Bohîlţea ◽  
Octavian Munteanu ◽  
Oana Bodean ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document